Kestra Medical Technologies, Ltd. (KMTS)

Market Cap	1.31B +7.1%
Revenue (ttm)	83.72M +59.1%
Net Income	-148.12M
EPS	-3.00
Shares Out	58.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	192,070
Open	22.85
Previous Close	22.72
Day's Range	21.61 - 23.87
52-Week Range	13.25 - 30.00
Beta	n/a
Analysts	Buy
Price Target	26.75 (+19.15%)
Earnings Date	Mar 17, 2026

About KMTS

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardiovert...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 6, 2025
• Employees: 330
• Stock Exchange: NASDAQ
• Ticker Symbol: KMTS
• Website: https://kestramedical.com

Financial Performance

In fiscal year 2025, KMTS's revenue was $59.82 million, an increase of 115.05% compared to the previous year's $27.81 million. Losses were -$126.14 million, 25.1% more than in 2024.

Analyst Summary

According to 4 analysts, the average rating for KMTS stock is "Buy." The 12-month stock price target is $26.75, which is an increase of 19.15% from the latest price.

Price Target

$26.75

(19.15% upside)

Analyst Consensus: Buy